PT99727A - Processo para a preparacao de composicoes farmaceuticas estaveis de calcitonina humana - Google Patents

Processo para a preparacao de composicoes farmaceuticas estaveis de calcitonina humana

Info

Publication number
PT99727A
PT99727A PT99727A PT9972791A PT99727A PT 99727 A PT99727 A PT 99727A PT 99727 A PT99727 A PT 99727A PT 9972791 A PT9972791 A PT 9972791A PT 99727 A PT99727 A PT 99727A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
human calcitonin
stabilized pharmaceutical
preparing human
acid
Prior art date
Application number
PT99727A
Other languages
English (en)
Other versions
PT99727B (pt
Inventor
Tudor Arvinte
Katherine Diana Ryman
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909026882A external-priority patent/GB9026882D0/en
Priority claimed from GB919119048A external-priority patent/GB9119048D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT99727A publication Critical patent/PT99727A/pt
Publication of PT99727B publication Critical patent/PT99727B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • External Artificial Organs (AREA)
PT99727A 1990-12-11 1991-12-09 Processo para a preparacao de composicoes farmaceuticas estaveis de calcitonina humana PT99727B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909026882A GB9026882D0 (en) 1990-12-11 1990-12-11 Pharmaceutical compositions
GB919119048A GB9119048D0 (en) 1991-09-06 1991-09-06 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PT99727A true PT99727A (pt) 1992-10-30
PT99727B PT99727B (pt) 1999-05-31

Family

ID=26298092

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99727A PT99727B (pt) 1990-12-11 1991-12-09 Processo para a preparacao de composicoes farmaceuticas estaveis de calcitonina humana

Country Status (16)

Country Link
EP (1) EP0490549B1 (pt)
JP (1) JP3179538B2 (pt)
KR (1) KR100253862B1 (pt)
AT (1) ATE124869T1 (pt)
AU (1) AU653371B2 (pt)
CA (1) CA2057291C (pt)
DE (1) DE69111205T2 (pt)
DK (1) DK0490549T3 (pt)
ES (1) ES2074236T3 (pt)
HU (1) HU213204B (pt)
IE (1) IE66398B1 (pt)
IL (1) IL100239A (pt)
MX (1) MX9102446A (pt)
NZ (1) NZ240901A (pt)
PH (1) PH30776A (pt)
PT (1) PT99727B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5397479A (en) * 1993-04-26 1995-03-14 International Remote Imaging Systems, Inc. Composition and method for enrichment of white blood cells from whole human blood
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
SI9720025A (sl) 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Spojine in sestavki za prenos aktivne snovi
CA2258264A1 (en) 1996-06-14 1997-12-18 Emisphere Technologies, Inc. Microencapsulated fragrances and method for preparation
US5726154A (en) * 1996-06-28 1998-03-10 University Of Utah Research Foundation Stabilization and oral delivery of calcitonin
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6502208B1 (en) 1997-03-31 2002-12-31 International Business Machines Corporation Method and system for check stop error handling
KR100611559B1 (ko) * 1998-05-08 2007-04-25 동아제약주식회사 칼시토닌을 함유한 비강투여용 약제학적 조성물
EP1232753B1 (en) * 1999-09-08 2008-03-19 Chugai Seiyaku Kabushiki Kaisha Stable protein solution filled in a container made from a hydrophobic resin and method of stabilizing the same
JP3498041B2 (ja) 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
MX2007015476A (es) 2005-06-14 2008-02-25 Amgen Inc Formulaciones de proteina autoamortiguadoras.
EP2471554A1 (en) * 2010-12-28 2012-07-04 Hexal AG Pharmaceutical formulation comprising a biopharmaceutical drug
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
AU2017345490B2 (en) 2016-10-21 2022-07-07 Amgen Inc. Pharmaceutical formulations and methods of making the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657858A5 (de) * 1983-06-27 1986-09-30 Ciba Geigy Ag Substanz aus der gruppe der calcitonine.
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
US5059587A (en) * 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
ATE90570T1 (de) * 1988-01-29 1993-07-15 Sumitomo Pharma Verbesserte formulierungen mit kontrollierter abgabe.
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
JPH02174726A (ja) * 1988-12-23 1990-07-06 Toyo Jozo Co Ltd エルカトニン水溶液組成物の安定化法
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物

Also Published As

Publication number Publication date
HU213204B (en) 1997-03-28
IL100239A0 (en) 1992-09-06
AU8889891A (en) 1992-06-18
ATE124869T1 (de) 1995-07-15
JP3179538B2 (ja) 2001-06-25
DE69111205D1 (de) 1995-08-17
PH30776A (en) 1997-10-17
IL100239A (en) 1996-06-18
IE914294A1 (en) 1992-06-17
AU653371B2 (en) 1994-09-29
PT99727B (pt) 1999-05-31
MX9102446A (es) 1992-07-01
EP0490549B1 (en) 1995-07-12
IE66398B1 (en) 1995-12-27
CA2057291A1 (en) 1992-06-12
KR100253862B1 (ko) 2000-09-01
DE69111205T2 (de) 1996-01-04
CA2057291C (en) 2003-09-09
JPH06340547A (ja) 1994-12-13
DK0490549T3 (da) 1995-08-21
HU913887D0 (en) 1992-02-28
ES2074236T3 (es) 1995-09-01
KR920011516A (ko) 1992-07-24
NZ240901A (en) 1993-03-26
EP0490549A1 (en) 1992-06-17
HUT59832A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
PT99727A (pt) Processo para a preparacao de composicoes farmaceuticas estaveis de calcitonina humana
SE8101065L (sv) Antitrombinberedning
FI98460B (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
BR8700386A (pt) Composicoes acidas pseudoplasticas
PT84663B (pt) Processo para a preparacao de novas composicoes farmaceuticas de accao prolongada contendo compostos activos praticamente insoluveis, especialmente dihidropiridinas substituidas
SE8601103D0 (sv) Neue, schwefelhaltige 5-substituierte benzimidazol-derivate und verfahren zu ihrer herstellung
PT93946A (pt) Processo para a preparacao de sais de azelastina com solubilidade melhorada e de composicoes farmaceuticas que os contem
FI903486A7 (fi) Substituoidut a-pyridmidinyylioksi(tio)- ja a-triatsinyylioksi(tio)karboksyylihappojohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö herbisidisen, fungisidisen ja kasvien kasvua säätelevän vaikutu ksen omaavina aineina
PT90362A (pt) Metodo para o tratamento de doencas muco-epiteliais e da pele em mamiferos que utiliza acidos 4-quinolinocarboxilicos e seus derivados e processo para a preparacao de composicoes farmaceuticas que contem os mesmos compostos
ATE65401T1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
FR2600862B1 (fr) Compositions aqueuses contenant un compose cationique et de la gomme xanthane et procede de preparation.
BR9400062A (pt) Processo de preparação de uma solução diluída e estável de pelo menos um composto de 3-isotiazolona, e composição
JPS6413016A (en) Skin external preparation
FI910394A7 (fi) Substituoituja B-pyrimidinyylioksi(tio)-ja B-triatsinyylioksi(tio)sykloalkyylikarboksyylihappojohdannaisia, menetelmä niiden valmistamiseksija niiden käyttö aineina, joilla on herbisidinen, fungisidinen ja kasvien kasvua säätelevä vaikutus
PT92483A (pt) Processo para a preparacao de solucoes aquosas de doxorubicina
BR8901329A (pt) Derivados reativos de zirconio e processo para a sua preparacao
PT99146A (pt) Processo para a preparacao de complexos de inclusao com silibinina e de composicoes farmaceuticas que os contem
IT1215340B (it) Derivati di esteri dell'acido immidazol-1-il-carbossilico, procedimenti per la loro preparazione e composizioni fungicide che contengono il derivato come componente attivo.
PT81066B (pt) Processo para a preparacao de derivados de arfamenina (acido 5-amino-8-guanidino-4-oxo-2-fenilmetil-octanoico) e de composicoes farmaceuticas que os contem
DK214884A (da) Chlorphenoxyacetatderivat
EE02938B1 (et) p-hüdroksübensoehappe derivaadid, nende valmistamismeetod ja kasutamine ravimitena
JPS54148753A (en) Antibiotic of aminoglycoside and its preparation

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920617

FG3A Patent granted, date of granting

Effective date: 19990218

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20100818